Increased tyrosine hydroxylase activity after drug-induced alteration of sympathetic transmission.
D000311:Adrenal Glands / Q000187:drug effects / Q000201:enzymology*; D000818:Animals; D002395:Catecholamines / Q000494:pharmacology*; D004298:Dopamine; D005725:Ganglia, Autonomic / Q000187:drug effects / Q000201:enzymology; D008297:Male; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D010627:Phenethylamines / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*; D013268:Stimulation, Chemical; D009435:Synaptic Transmission / Q000187:drug effects; D014443:Tyrosine
D002395:Catecholamines; D010627:Phenethylamines; D010643:Phenoxybenzamine; D014443:Tyrosine; D012110:Reserpine; D006899:Mixed Function Oxygenases; D004298:Dopamine